文献速递肝胆胰外科围术期管理与 ERAS

血清胰淀粉酶动态风险分层预测胰十二指肠切除术后胰瘘

Impact of dynamic risk stratification for postoperative pancreatic fistula using serum pancreatic amylase on the day after pancreatoduodenectomy.
PubMed 文献 · Surgery · 2025-06-02

本研究基于234例胰十二指肠切除术患者,利用术后第1至3天的血清胰淀粉酶、引流液淀粉酶和C反应蛋白建立动态风险分层,发现术后第1天血清胰淀粉酶≥75 U/L和引流液淀粉酶≥2,000 U/L是临床相关术后胰瘘的独立危险因素,联合术后第2天C反应蛋白可提高诊断准确性,术后第3天评估可识别75%的高风险患者,准确率达87%。

要点

  • 术后第1天血清胰淀粉酶≥75 U/L是临床相关胰瘘的独立危险因素(OR 18.0)。
  • 术后第1天引流液淀粉酶≥2,000 U/L也是独立危险因素(OR 3.45)。
  • 动态联合术后第2天C反应蛋白和术后第3天指标可提高风险分层准确性至87%。

核心结论

  • 利用术后第1天血清胰淀粉酶进行动态风险分层,可逐步提高识别胰十二指肠切除术后临床相关胰瘘高风险患者的准确性。
  • 联合术后第1天血清胰淀粉酶、术后第3天引流液淀粉酶和C反应蛋白的风险评估可识别75%的最高风险患者,准确率87%。

研究设计与样本

  • 回顾性分析234例接受胰十二指肠切除术患者的资料,采用多变量分析评估术后第1至3天可用的生物标志物。

主要发现

  • 临床相关术后胰瘘、C级胰瘘和胰切除后出血分别发生于56例(24%)、12例(5%)和24例(10%)患者。
  • 术后第1天血清胰淀粉酶≥75 U/L和引流液淀粉酶≥2,000 U/L是临床相关胰瘘的独立危险因素(OR分别为18.0和3.45)。
  • 在术后第1天分层基础上加入术后第2天C反应蛋白可提高诊断准确性(OR 3.19)。
  • 术后第3天风险评估使用术后第1天血清胰淀粉酶≥75 U/L、术后第3天引流液淀粉酶≥5,000 U/L和术后第3天C反应蛋白≥22 mg/L,识别75%最高风险患者(OR分别为19.7、5.41和5.01),准确率87%。

关键数值与推荐

  • 术后第1天血清胰淀粉酶≥75 U/L(OR 18.0)和引流液淀粉酶≥2,000 U/L(OR 3.45)为独立危险因素。
  • 术后第2天C反应蛋白加入第1天分层可提高准确性(OR 3.19)。
  • 术后第3天高风险标准:术后第1天血清胰淀粉酶≥75 U/L、术后第3天引流液淀粉酶≥5,000 U/L、术后第3天C反应蛋白≥22 mg/L(OR分别为19.7、5.41、5.01),准确率87%。

临床怎么用

  • 术后第1天检测血清胰淀粉酶和引流液淀粉酶,初步识别临床相关胰瘘高风险患者。
  • 术后第2天加入C反应蛋白,动态更新风险分层。
  • 术后第3天联合血清胰淀粉酶、引流液淀粉酶和C反应蛋白进行综合评估,早期识别最高风险患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: An appropriate combination of various biomarkers, including serum pancreatic amylase, drain amylase, and C-reactive protein levels, is pivotal for assessing the dynamic changes in patient status after pancreatoduodenectomy. This study aimed to establish a dynamic risk stratification for clinically relevant postoperative pancreatic fistula using clinically applicable parameters on postoperative days 1 to 3. METHODS: Data from 234 patients who underwent pancreatoduodenectomy were analyzed. Multivariate analyses were conducted using biomarkers available on postoperative days 1 to 3. RESULTS: Clinically relevant postoperative pancreatic fistula, grade C postoperative pancreatic fistula, and postpancreatectomy hemorrhage were observed in 56 (24%), 12 (5%), and 24 (10%) patients, respectively. Although the prognostic value of drain amylase and C-reactive protein improved over time, serum pancreatic amylase levels on postoperative days 1 and 2 were equally predictive of clinically relevant postoperative pancreatic fistula. Patients with high levels of serum pancreatic amylase had significantly high fistula risk scores. Multivariate analysis revealed that serum pancreatic amylase ≥75 U/L and drain amylase ≥2,000 U/L on postoperative day 1 were independent risk factors (odds ratio: 18.0 and 3.45, respectively). Adding C-reactive protein on postoperative day 2 to the stratification on postoperative day 1 improved the diagnostic accuracy (odds ratio: 3.19). Finally, risk assessment on postoperative day 3, using serum pancreatic amylase ≥75 U/L on postoperative day 1, drain amylase ≥5,000 U/L on postoperative day 3, and C-reactive protein ≥22 mg/L on postoperative day 3, identified 75% of patients at highest risk for clinically relevant postoperative pancreatic fistula (odds ratio: 19.7, 5.41, and 5.01, respectively), with an accuracy of 87%. CONCLUSIONS: Dynamic risk stratification using serum pancreatic amylase on postoperative day 1 gradually increased the accuracy of identifying high-risk patients from postoperative days 1 to 3. Using suitable biomarkers, including those at each perioperative stage, can facilitate the early identification of high-risk patients.

来源:Surgery,查看原文。版权归原作者所有。

引用

  1. Kato T, Murase Y, Baba Y, et al. Impact of dynamic risk stratification for postoperative pancreatic fistula using serum pancreatic amylase on the day after pancreatoduodenectomy. Surgery. 2025. PMID: 40460557. doi:10.1016/j.surg.2025.109454

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。